Filters close
2-Dec-2022 8:05 AM EST
Symptoms of long Covid in children may change over time
University College London

New symptoms may appear in children up to a year after initial infection with Covid-19, finds a new study led by UCL researchers.

Released: 2-Dec-2022 4:45 PM EST
Fred Hutch at ASH: Global insights on AML outcomes, COVID-19 and cancer, CD19 CAR T-cell therapy updates, latest on precision oncology — and more
Fred Hutchinson Cancer Center

SEATTLE — Dec. 1, 2022 — The 64th Annual Meeting and Exposition of the American Society of Hematology (ASH) will take place virtually and in person Dec. 10-13 in New Orleans, Louisiana.

Newswise: Where did Omicron come from?
Released: 2-Dec-2022 10:50 AM EST
Where did Omicron come from?
Charité - Universitätsmedizin Berlin

First discovered a year ago in South Africa, the SARS-CoV-2 variant later dubbed “Omicron” spread across the globe at incredible speed.

Not for public release

This news release is embargoed until 2-Dec-2022 12:15 AM EST Released to reporters: 29-Nov-2022 4:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 2-Dec-2022 12:15 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 1-Dec-2022 7:55 PM EST
Immune T cell defence is coping with COVID-19 variants of concern – for now
University of Birmingham

Immune T cells are continuing to target the spike protein of SARS-CoV-2 variants of concern, although mutations are making some T cells less effective, according to new research.

Newswise: Experimental COVID-19 Vaccine Offers Long-term Protection Against Severe Disease
Released: 1-Dec-2022 2:30 PM EST
Experimental COVID-19 Vaccine Offers Long-term Protection Against Severe Disease
University of North Carolina School of Medicine

SARS-CoV-2 vaccines protected infant rhesus macaques against 1 severe lung disease after high dose challenge one year after vaccination.

29-Nov-2022 7:55 PM EST
Long COVID patients and those with other illnesses experience similar, negative lingering effects during the pandemic
University of California, Los Angeles (UCLA), Health Sciences

Long COVID patients can experience many of the same lingering negative effects on their physical, mental, and social well-being as those experienced by people who become ill with other, non-COVID illnesses.

Released: 1-Dec-2022 10:05 AM EST
Bruma mental después de la covid: experto de Mayo Clinic describe los signos frecuentes
Mayo Clinic

uando comenzó la pandemia de COVID-19, los pacientes con síndrome de covid prolongada, también conocido como síndrome poscovid, informaron que tenían problemas con el pensamiento. A esto, se ha llegado a conocer como bruma mental y, aunque no sea el término médico oficial, la expresión es ahora una parte permanente de la discusión sobre la covid prolongada. En esta advertencia de un experto, el Dr. Greg Vanichkachorn, director del Programa para rehabilitación de la actividad después de la covid en Mayo Clinic, describe los problemas frecuentes de los pacientes.

Released: 1-Dec-2022 9:00 AM EST
Confusão mental pós-COVID: especialista da Mayo Clinic descreve os sintomas comuns
Mayo Clinic

Nos primeiros dias da pandemia de COVID-19, pacientes com a síndrome da COVID longa (também conhecida como síndrome pós-COVID), relataram problemas de raciocínio. Isso ficou conhecido como confusão ou névoa mental e, embora não seja um termo médico oficial, tornou-se parte permanente da discussão sobre a COVID longa. Neste alerta do especialista, o Dr. Greg Vanichkachorn, M.D., diretor do Programa de Reabilitação de Atividades da COVID da Mayo Clinic, descreve os problemas comuns vivenciados pelos pacientes.

Released: 1-Dec-2022 1:05 AM EST
ضباب الدماغ ما بعد فيروس كورونا المستجد: خبير من مايو كلينك يصف المؤشرات الشائعة
Mayo Clinic

مدينة روتشستر، ولاية مينيسوتا— في الأيام الأولى لجائحة فيروس كورونا المستجد (كوفيد-19)، أبلغ المرضى المصابون بمتلازمة فيروس كورونا المستجد طويل الأمد، والمعروفة أيضًا باسم متلازمة ما بعد فيروس كورونا المستجد، عن مشاكل في التفكير. ثم أصبح هذا يُعرف باسم ضباب الدماغ، وعلى الرغم من أنه ليس مصطلحًا طبيًا رسميًا، فقد أصبح جزءًا دائمًا من مناقشات فيروس كورونا المستجد طويل الأمد. وفي هذا المقال، يصف جريج فانيشكاتورن، دكتور الطب، مدير برنامج مايو كلينك لتأهيل النشاط بعد فيروس كورونا المستجد، المشكلات الشائعة التي يعاني منها المرضى.

Released: 30-Nov-2022 6:45 PM EST
Overweight women most likely to suffer long Covid
University of East Anglia

Overweight women are more likely to experience symptoms of long Covid according to new research from the University of East Anglia.

Released: 30-Nov-2022 4:50 PM EST
Americans Report Sleeping Better, Two Years into the Pandemic
American Academy of Sleep Medicine (AASM)

A survey from the American Academy of Sleep Medicine reveals that Americans seem to be sleeping better now compared with 2021. Nearly one-third of Americans (31%) say they have experienced “COVID-somnia" since the beginning of the pandemic, a 25% decrease compared with the 2021 survey (56%).

Released: 30-Nov-2022 12:40 PM EST
Clover’s vaccine candidate reduced household transmission of SARS-CoV-2 in study
International Vaccine Institute

The study, a collaboration between Clover and the International Vaccine Institute, showed that a household contact was 84% less likely to get a SARS-CoV-2 infection when the infected household member had received SCB-2019 (CpG 1018/Alum) compared to placebo

Released: 30-Nov-2022 12:35 PM EST
Post-pandemic outbreak of drug-resistant fungus in Brazil owing to abuse of medications and full up ICUs
Sao Paulo Research Foundation (FAPESP)

In Brazil, a group of researchers has reported the largest outbreak to date of COVID-associated candidemia caused by the same drug-resistant strain of Candida parapsilosis, a fungus that invades the bloodstream and can lead to death.

Released: 30-Nov-2022 11:30 AM EST
Research reveals how a potentially fatal COVID-19 complication damages lung tissue
University of Texas Health Science Center at Houston

Mechanisms involved in the rapid, severe progression of fibrosis in the lung tissues of COVID-19 patients, a potentially fatal complication of the virus that damages and scars the lungs, have been uncovered by researchers led by UTHealth Houston.

Newswise:Video Embedded preparing-for-a-tripledemic-holiday-season
VIDEO
Released: 30-Nov-2022 11:00 AM EST
Preparing for a ‘Tripledemic’ Holiday Season
Cedars-Sinai

With COVID-19 and flu cases rising, and RSV (respiratory syncytial virus) affecting many young children, experts are bracing for a “tripledemic” of respiratory viruses this holiday season.

Released: 29-Nov-2022 8:45 PM EST
Engineered proteins: A future treatment option for COVID-19
Texas A&M University

COVID-19 has had a lasting global health impact that continues to challenge the health care system.

   
Released: 29-Nov-2022 7:05 PM EST
Ethiopian schools study suggests COVID has “ruptured” social skills of the world’s poorest children
University of Cambridge

School closures during the COVID-19 pandemic have “severely ruptured” the social and emotional development of some of the world’s poorest children, as well as their academic progress, new evidence shows.

Newswise: Study Shows Paxlovid Can Safely Be Used to Reduce Risk of Severe COVID in People Who Are Pregnant
Released: 29-Nov-2022 5:25 PM EST
Study Shows Paxlovid Can Safely Be Used to Reduce Risk of Severe COVID in People Who Are Pregnant
Johns Hopkins Medicine

Findings from a Johns Hopkins Medicine research study published today in JAMA Network Open provide strong evidence that people who are pregnant and have been infected with SARS-CoV-2 (the virus that causes COVID-19) can safely take the antiviral drug Paxlovid to reduce the possibility of severe disease.

Newswise: COVID-19 vaccine’s effectiveness diminishes with age, research shows
Released: 29-Nov-2022 4:00 PM EST
COVID-19 vaccine’s effectiveness diminishes with age, research shows
UT Southwestern Medical Center

The Pfizer-BioNTech COVID-19 vaccine limits transmission, hospitalization, and death from COVID-19 even among patients infected by variants of the virus, but the effectiveness of antibodies it generates diminishes as patients get older, according to a study by UT Southwestern researchers.

Released: 29-Nov-2022 2:50 PM EST
Adapting language models to track virus variants
Argonne National Laboratory

Groundbreaking research by Argonne National Laboratory finds new method to quickly identify COVID-19 virus variants. Their work wins the Gordon Bell Special Prize.

Released: 29-Nov-2022 1:10 PM EST
Young people make up greater proportion of COVID-19 deaths in 2021 compared to 2020
Brigham and Women’s Hospital

Since March 2020, COVID-19-related deaths claimed over a million lives in the U.S. alone.

Released: 28-Nov-2022 7:30 PM EST
COVID lockdown did not lead to a rush on opioid prescriptions
Columbia University, Mailman School of Public Health

While some feared that New Yorkers would re-fill prescriptions to stockpile opioid medications in the early weeks of the COVID-19 lockdown much in the way people hoarded toilet paper, in fact, New York State opioid prescriptions declined in the period around the March 20, 2020 “PAUSE” order, according to new research.

21-Nov-2022 2:05 PM EST
ACP issues Rapid, Living Practice Points on treating COVID-19 patients in outpatient settings
American College of Physicians (ACP)

In a new Rapid and Living Practice Points, the American College of Physicians (ACP) summarizes the best available evidence about the use of pharmacologic and biologic treatments of COVID-19 in the outpatient setting. Outpatient Treatment of Confirmed Mild or Moderate COVID-19: Living and Rapid Practice Points from the American College of Physicians (Version 1), is published in Annals of Internal Medicine.

21-Nov-2022 2:05 PM EST
Despite fewer overall COVID-19 deaths, more younger people died in second year of the pandemic
American College of Physicians (ACP)

A brief research report found that despite 20.8 percent fewer COVID-19 deaths occurring in the second year of the COVID-19 pandemic, 7.4 percent more years of life were lost due to a shift in COVID-19 mortality to relatively younger people. The report is published in Annals of Internal Medicine.

21-Nov-2022 2:05 PM EST
Critical changes in COVID-19 standards of care associated with improved mortality outcomes
American College of Physicians (ACP)

An observational study of COVID-19 standard of care (SOC) measures found improvements in recovery and mortality over time in adults hospitalized with COVID-19 and investigated changes in SOC that may explain these improvements. The study is published in Annals of Internal Medicine.

21-Nov-2022 2:05 PM EST
In some settings, medical masks may offer similar effectiveness to N95 respirators for preventing COVID-19 infection among health care workers
American College of Physicians (ACP)

A study of more than 1,000 health care workers was unable to establish whether medical masks are significantly less effective at preventing COVID-19 infection than N95 respirators in hospital settings. The findings varied across countries, which were studied during different times in the pandemic, and uncertainty in the estimates of effect limit definitiveness of findings. The study is published in Annals of Internal Medicine.

Released: 28-Nov-2022 12:55 PM EST
Community pharmacy-led vaccination scheme helped thousands of patients overcome hesitancy around Covid-19 jabs, research finds
Kingston University

An award-winning scheme that saw community pharmacists support patients to understand the benefits of being jabbed against Covid-19 and overcome initial hesitancy proved hugely successful, new research by an expert from Kingston University has shown.

Newswise: Dr. Fauci reflects on the perpetual challenge of infectious diseases
Released: 28-Nov-2022 12:20 PM EST
Dr. Fauci reflects on the perpetual challenge of infectious diseases
NIH, National Institute of Allergy and Infectious Diseases (NIAID)

Once considered a potentially static field of medicine, the discipline of studying infectious diseases has proven to be dynamic as emerging and reemerging infectious diseases present continuous challenges, Anthony S. Fauci, M.D., writes in a perspective in The New England Journal of Medicine.

27-Nov-2022 9:05 AM EST
Gut Microbes Disturbed by COVID-19 Infection, Especially with Antibiotics
Rutgers University-New Brunswick

In an intensive look at the effects of the virus causing COVID-19 on patients’ microbiome – the collection of microorganisms that live in and on the human body – Rutgers scientists found that acute infection disrupts a healthy balance between good and bad microbes in the gut, especially with antibiotic treatment.

Released: 28-Nov-2022 9:00 AM EST
Links Between Neurological Involvement and Respiratory Damage in SARS-CoV-2 Infection
Sbarro Health Research Organization (SHRO)

Researchers working with Sbarro Health Research Organization (SHRO) have published a paper examining the possible links between neurological involvement and respiratory damage due to COVID-19.

Released: 24-Nov-2022 11:45 AM EST
How COVID-19 school closures will affect inequalities in adult skills
International Institute for Applied Systems Analysis (IIASA)

School closures due to the COVID-19 pandemic affected learning to varying degrees in different countries. A new study sheds light on what this learning loss will mean for countries' human capital in the decades to come.

Newswise: Pocket feature shared by deadly coronaviruses could lead to pan-coronavirus antiviral treatment
Released: 23-Nov-2022 2:00 PM EST
Pocket feature shared by deadly coronaviruses could lead to pan-coronavirus antiviral treatment
University of Bristol

Researchers of the University of Bristol-led study, published in Science Advances today [23 November], say their findings could lead to the development of a pan-coronavirus treatment to defeat all coronaviruses.

Released: 23-Nov-2022 10:55 AM EST
Scientists discover new mechanism associated with severe COVID-19
Sao Paulo Research Foundation (FAPESP)

Researchers at the University of São Paulo (USP) in Brazil have found that severe COVID-19 is associated with an imbalance in an important immune system signaling pathway.

Released: 23-Nov-2022 10:25 AM EST
What was the true human cost of the pandemic in Russia?
International Institute for Applied Systems Analysis (IIASA)

A new study assesses the number of lives lost to the COVID-19 pandemic in Russia and introduces a novel methodology that will help to get a clearer view of pandemics in the future.

   
Released: 22-Nov-2022 7:55 PM EST
Fear of COVID-19 continues to impact adversely on psychological wellbeing
Swansea University

Research by psychologists from the School of Psychology at Swansea University found that people’s fear of COVID-19 has led to worsened mental health.

Newswise: Remdesivir reduces COVID-19 mortality in a real-world setting
Released: 22-Nov-2022 7:45 PM EST
Remdesivir reduces COVID-19 mortality in a real-world setting
Tokyo Medical and Dental University

The COVID-19 pandemic has led to an explosion of clinical research resulting in the development of a variety of vaccines and treatments, although the efficacy of some remains controversial.

Released: 22-Nov-2022 2:35 PM EST
A growing trend of antibody evasion by new omicron subvariants
Ohio State University

Three currently circulating omicron subvariants of SARS-CoV-2 – including two that currently make up almost 50% of reported COVID-19 infections in the U.S. – are better at evading vaccine- and infection-generated neutralizing antibodies than earlier versions of omicron, new research suggests.

Newswise: Risk of severe COVID-19 symptoms remains throughout pregnancy, study finds
Released: 22-Nov-2022 2:05 PM EST
Risk of severe COVID-19 symptoms remains throughout pregnancy, study finds
UT Southwestern Medical Center

A UT Southwestern study of more than 1,300 pregnant women diagnosed with COVID-19 found that just 1 in 10 developed moderate, severe, or critical illness and that COVID-19 symptoms and severity were similar across all trimesters.

21-Nov-2022 10:05 AM EST
COVID-19 vaccine gives substantial protection against reinfection
PLOS

Individuals previously infected with SARS-CoV-2, the virus that causes COVID-19, still benefit from vaccination, gaining 60% to 94% protection against reinfection, depending on the variant. A new study led by Katrine Finderup Nielsen at Statens Serum Institut, Denmark, reports these findings November 22nd in the open access journal PLOS Medicine.

Released: 22-Nov-2022 12:25 PM EST
Researchers study postgraduate students’ mental health during Covid-19 pandemic static managements
Tsinghua University Press

A team of researchers undertook a study of the mental health of postgraduate students during the Covid-19 pandemic static management.

Newswise: NIH establishes website for self-reporting COVID-19 test results
Released: 22-Nov-2022 12:00 PM EST
NIH establishes website for self-reporting COVID-19 test results
National Institute of Biomedical Imaging and Bioengineering

Reporting a positive or negative test result just became easier through a new website from the National Institutes of Health. MakeMyTestCount.org, developed through NIH’s Rapid Acceleration of Diagnostics (RADx®) Tech program, allows users to anonymously report the results of any brand of at-home COVID-19 test.

Newswise: The Interplay Between Epidemics, Prevention Information, and Mass Media
16-Nov-2022 10:25 AM EST
The Interplay Between Epidemics, Prevention Information, and Mass Media
American Institute of Physics (AIP)

When an epidemic strikes, more than just infections spread. As cases mount, information about the disease, how to spot it, and how to prevent it propagates rapidly among people in affected areas as well.

   
Newswise: Senta Georgia, PhD, Receives Hutton Rising Star Award From Fellow Beta Cell Researchers
Released: 22-Nov-2022 8:05 AM EST
Senta Georgia, PhD, Receives Hutton Rising Star Award From Fellow Beta Cell Researchers
Children's Hospital Los Angeles

The principal investigator in the Center for Endocrinology, Diabetes and Metabolism at Children’s Hospital Los Angeles is being honored at WRISG—the Western Region Islet Study Group’s beta cell research meeting. Senta Georgia, PhD, first attended the Western Region Islet Study Group (WRISG) meeting as a graduate student in 2004.

21-Nov-2022 11:05 AM EST
Nation’s Health Care Organizations Urge COVID-19 and Influenza Vaccination and Treatment
American College of Physicians (ACP)

Given the anticipated increase in COVID-19 and influenza cases this fall and winter, America’s healthcare professional organizations are coming together to remind the public of the importance of vaccinations and early treatment.

Released: 21-Nov-2022 11:35 AM EST
Study finds that risk of myocarditis after SARS-CoV-2 vaccination is increased but very low
Canadian Medical Association Journal

A large study found that myocarditis after SARS-CoV-2 vaccination was rare but higher in younger males, especially after the second mRNA-1273 (Moderna) vaccine, suggesting that vaccine type, age and sex should be considered when vaccinating.

Newswise: National Poll: 1 in 7 parents haven’t discussed vaccines with their child’s primary care provider during pandemic period
17-Nov-2022 8:20 AM EST
National Poll: 1 in 7 parents haven’t discussed vaccines with their child’s primary care provider during pandemic period
Michigan Medicine - University of Michigan

Parents may not always turn to health professionals for vaccine advice – and a small subset could even be avoiding the conversation – a new national poll suggests.



close
6.71036